Clinical trial
TO-ChERIsH: Trajectory of Cardiovascular Ageing, Its Determinants and Impact on Health
NCT04501562 is registered in ClinicalTrials.gov with National Heart Centre Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TO-ChERIsH: Trajectory of Cardiovascular Ageing, Its Determinants and Impact on Health
- Lead sponsor
- National Heart Centre Singapore
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 13, 2019
- Completion date
- December 31, 2049
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac ageing